GO:0008283 cell population proliferation: Core Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008283 (cell population proliferation) is defined as the multiplication or reproduction of cells, resulting in the expansion of a cell population.
• Proliferation is driven by cell-cycle entry and progression, and is modulated by growth factors, metabolic state, and tissue microenvironment.
• Proliferation rates differ between individuals and cell types, and can be quantified in model systems such as HapMap cell lines.
• Local proliferation of specific progenitors, such as MafB-restricted monocytes, precedes differentiation into tissue macrophages.
• Dysregulated proliferation is a hallmark of cancer and is also implicated in fibrotic remodeling and immune cell expansion [4, 5, 8].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of proliferation-related genes.
Description
Cell population proliferation (GO:0008283) is a fundamental biological process defined as the multiplication or reproduction of cells, resulting in the expansion of a cell population. This process underlies tissue development, homeostasis, regeneration, and immune responses, and its dysregulation contributes to diseases such as cancer and fibrosis [4, 5]. Understanding the genetic and environmental factors that control proliferation is therefore central to both basic and translational research. Studies using international HapMap cell lines have shown that the rate of proliferation varies significantly between individuals and populations, highlighting the importance of genetic background in experimental models. In parallel, work on immune cell dynamics has demonstrated that local proliferation of specific progenitor populations, such as MafB-restricted monocytes, is a prerequisite for subsequent differentiation into lung interstitial macrophages. These findings illustrate that proliferation is not a uniform process but is tightly regulated in a cell-type-specific manner. This article provides a research-grade overview of GO:0008283, covering its definition, mechanisms, key genes, disease relevance, and experimental methods for studying proliferation.
cell population proliferation At A Glance
| GO ID | GO:0008283 |
|---|---|
| GO term | cell population proliferation |
| Ontology | biological_process |
| Synonym | cell proliferation |
| Definition | The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
| Major function | Expansion of cell numbers during development, homeostasis, immune responses, and tissue repair. |
| Related processes | Cell cycle, growth factor signaling, apoptosis, differentiation. |
| Disease relevance | Cancer, fibrosis, autoimmune disorders, and other proliferative pathologies. |
What Is GO:0008283?
According to the Gene Ontology, cell population proliferation (GO:0008283) is the biological process in which cells multiply or reproduce, leading to an increase in the total number of cells in a population. This definition encompasses both the cell division cycle and the signals that trigger or sustain it, and it applies to normal development, tissue repair, and pathological expansion of cell populations.
Why Is cell population proliferation Important in Cell Biology?
Cell population proliferation is essential for understanding how tissues grow, maintain themselves, and respond to injury, and how these processes go awry in disease. For example, in pulmonary fibrosis, multiple stromal populations expand without evidence for epithelial-to-mesenchymal transition, underscoring the role of proliferation in fibrotic remodeling. In bladder cancer, mitochondrial reprogramming via glutamine metabolism supports proliferation in African American patients, linking metabolism to proliferative capacity. Moreover, a secreted product from a murine B cell lymphoma can induce proliferation of normal T lymphocytes, illustrating how malignant cells can drive proliferation of bystander cells. These examples highlight that proliferation is a central node in both physiological and pathological contexts.
• Proliferation is required for embryonic development and tissue regeneration.
• It underlies clonal expansion of immune cells during infection and autoimmunity.
• Dysregulated proliferation is a hallmark of cancer, including prostate cancer and bladder cancer [1, 5].
• Proliferation of stromal cells contributes to fibrosis without epithelial-to-mesenchymal transition.
• Genetic variation influences proliferation rates, as shown in HapMap cell lines.
• Proliferation can be induced by secreted factors from malignant cells.
• Melanocyte proliferation is relevant to melanoma risk and biology.
• Metabolic reprogramming, such as OXPHOS activation via glutamine, supports proliferation in some cancers.
• Proliferation of specific monocyte subsets precedes macrophage differentiation in the lung.
• Measuring proliferation is a standard readout in drug discovery and CRISPR screens.
What Happens During cell population proliferation?
Growth factor signaling and cell cycle entry
In simple terms: Cells receive external signals that tell them to start dividing.
Proliferation begins when cells receive growth factor or mitogenic signals that activate intracellular pathways, leading to expression of cell cycle regulators and entry into the G1 phase. In immune contexts, local proliferation of MafB-restricted monocytes is triggered before they differentiate into lung interstitial macrophages. Similarly, a secreted product from a murine B cell lymphoma can induce proliferation of normal T lymphocytes, demonstrating that external factors can drive cell cycle entry in bystander cells.
DNA replication and mitosis
In simple terms: The cell copies its DNA and divides into two daughter cells.
Once committed, cells progress through S phase (DNA replication) and G2/M phases, ultimately dividing into two daughter cells. This core division cycle is conserved and is the engine of population expansion. The rate of proliferation can vary between cell lines from different individuals, as shown in international HapMap cell lines.
Metabolic support for proliferation
In simple terms: Dividing cells need extra energy and building blocks.
Proliferating cells reprogram their metabolism to meet biosynthetic demands. In bladder cancer, activation of oxidative phosphorylation (OXPHOS) via glutamine metabolism supports proliferation in African American patients. This link between metabolism and proliferation highlights that cell division is not only a matter of cell cycle machinery but also of metabolic capacity.
Proliferation in tissue remodeling and fibrosis
In simple terms: In some diseases, excessive cell division leads to scarring.
In pulmonary fibrosis, multiple stromal populations expand and contribute to fibrosis without evidence for epithelial-to-mesenchymal transition, indicating that proliferation of resident stromal cells is a key mechanism. This shows that proliferation can be pathogenic when it becomes chronic or uncontrolled.
Proliferation as a precursor to differentiation
In simple terms: Some cells divide first and then specialize.
In the immune system, local proliferation of monocyte progenitors precedes their differentiation into tissue macrophages, such as lung interstitial macrophages. This ordered sequence ensures an adequate supply of differentiated cells for tissue needs.
Key Genes Involved in GO:0008283 cell population proliferation
The following genes and proteins are representative regulators or markers of cell population proliferation, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MKI67 | Marker of proliferation | Used to assess proliferation in tissues and cell lines |
| PCNA | DNA replication processivity factor | Marker of S phase and proliferation |
| CCND1 | G1/S transition | Regulates cell cycle entry |
| CDK4 | G1 progression | Target of inhibitors in cancer |
| CDK6 | G1 progression | Regulates cell cycle entry |
| MYC | Transcription factor driving proliferation | Oncogene amplified in many cancers |
| TP53 | Cell cycle checkpoint and apoptosis | Tumor suppressor mutated in cancers |
| RB1 | G1/S checkpoint | Tumor suppressor controlling proliferation |
| EGFR | Growth factor receptor signaling | Drives proliferation in many cancers |
| KRAS | Mitogenic signaling | Oncogene mutated in cancers |
| PIK3CA | PI3K/AKT signaling | Promotes proliferation and survival |
| MTOR | Metabolic and growth control | Regulates proliferation in response to nutrients |
| GLUL | Glutamine metabolism | Supports proliferation via OXPHOS in bladder cancer |
| MAFB | Monocyte proliferation and differentiation | Restricts local monocyte proliferation before macrophage differentiation |
| GAL3ST2 | Chimeric RNA D2HGDH-GAL3ST2 | Detected in prostate cancer, potential proliferation link |
| D2HGDH | Mitochondrial metabolism | Part of recurrent cis-SAGe chimeric RNA in prostate cancer |
| ATP7B | Copper transport | Mutations cause Wilson's disease, may affect proliferation |
How Is cell population proliferation Regulated?
Cell population proliferation is regulated by a complex network of growth factors, cell cycle checkpoints, and metabolic signals. For instance, MafB restricts local monocyte proliferation before lung interstitial macrophage differentiation, acting as a brake on expansion. Metabolic reprogramming, such as activation of OXPHOS via glutamine metabolism, can promote proliferation in bladder cancer. Additionally, secreted factors from malignant B cells can induce proliferation of normal T lymphocytes, indicating paracrine regulation. These examples illustrate that proliferation is controlled at multiple levels, including transcriptional, metabolic, and microenvironmental.
cell population proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| D2HGDH-GAL3ST2 | Prostate cancer | Knock-in of chimeric RNA in prostate cell lines |
| GLUL | Bladder cancer | Knockout in bladder cancer cell lines to assess proliferation |
| MAFB | Lung interstitial macrophage differentiation | Conditional knockout in monocytes |
| ATP7B | Wilson's disease | Point mutation knock-in in hepatocyte models |
| GAL3ST2 | Prostate cancer | Overexpression in prostate epithelial cells |
Cancer
Uncontrolled proliferation is a hallmark of cancer. In prostate cancer, a recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, has been identified, suggesting a potential link to proliferative pathways. In bladder cancer, mitochondrial reprogramming by activating OXPHOS via glutamine metabolism supports proliferation in African American patients. Melanoma risk is also linked to melanocyte biology and proliferation.
Fibrosis
Pulmonary fibrosis involves expansion of multiple stromal populations without evidence for epithelial-to-mesenchymal transition, indicating that proliferation of resident stromal cells drives fibrotic remodeling.
Immune dysregulation
Local proliferation of MafB-restricted monocytes precedes lung interstitial macrophage differentiation, and dysregulation of this process may contribute to inflammatory lung diseases. Additionally, a secreted product from a murine B cell lymphoma can induce proliferation of normal T lymphocytes, highlighting how malignant cells can perturb immune cell proliferation.
Genetic disorders
Mutations in ATP7B cause Wilson's disease, and genetic studies have discovered novel coding and non-coding mutations in Chinese patients. While the direct link to proliferation is not fully established, copper metabolism can influence cell growth and division.
From cell population proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate proliferation? | CRISPR knockout in cell lines followed by proliferation assay |
| Does a point mutation in gene Y affect proliferation? | Point mutation knock-in via CRISPR |
| Does overexpression of gene Z drive proliferation? | CRISPR-mediated overexpression or cDNA transduction |
| Does a chimeric RNA affect proliferation? | Knock-in of fusion gene |
| Does metabolic gene A support proliferation? | Knockout and metabolic flux analysis |
| Does transcription factor B control monocyte proliferation? | Conditional knockout in primary monocytes |
How to Study the cell population proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU incorporation | DNA synthesis | Quantifying S-phase cells |
| MTT assay | Metabolic activity | Cell viability and proliferation |
| CFSE dilution | Cell division | Tracking proliferation of lymphocytes |
| Ki-67 staining | Proliferation marker | Tissue immunohistochemistry |
| RNA-seq | Transcriptome | Identifying proliferation-associated genes |
| Seahorse assay | OXPHOS and glycolysis | Metabolic support of proliferation |
| CRISPR screen | Gene function | Identifying regulators of proliferation |
Proliferation assays
Common methods include MTT, BrdU, EdU, and real-time cell analysis to measure cell number or DNA synthesis. These assays are used to quantify proliferation in response to genetic perturbations.
Flow cytometry
Flow cytometry with dyes such as CFSE or cell cycle markers (e.g., Ki-67, PI) allows assessment of proliferation and cell cycle distribution at the single-cell level.
RNA sequencing and transcriptomics
RNA-seq can identify gene expression changes associated with proliferation, such as upregulation of cell cycle genes or metabolic pathways.
Metabolic profiling
Seahorse analysis and metabolomics measure OXPHOS and glycolysis, which support proliferation under different conditions.
How CRISPR Can Be Used to Study GO:0008283 cell population proliferation
Knockout
CRISPR knockout is used to delete genes suspected to regulate proliferation, followed by proliferation assays to determine if the gene is required. For example, knocking out GLUL in bladder cancer cells can test its role in supporting proliferation via glutamine metabolism.
Point Mutation
Point mutations can be introduced to model specific variants, such as those in ATP7B found in Wilson's disease patients, and to assess their impact on proliferation.
Knock-in
Knock-in of chimeric RNAs, such as D2HGDH-GAL3ST2 identified in prostate cancer, allows functional studies of their role in proliferation.
Overexpression
Overexpression of candidate oncogenes or growth factors can drive proliferation and is used to validate gain-of-function effects. For instance, overexpressing GAL3ST2 in prostate cells can test its proliferative potential.
How EDITGENE Supports cell population proliferation Research
Researchers studying cell population proliferation-related genes often need to determine whether a candidate gene is causally involved in driving or restraining proliferation. This requires precise genetic models that can knockout, mutate, knock-in, or overexpress the gene of interest in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for cell population proliferation research.
Frequently Asked Questions About cell population proliferation
What is cell population proliferation?
Cell population proliferation (GO:0008283) is the biological process in which cells multiply or reproduce, leading to an increase in cell number.
What genes are involved in cell population proliferation?
Key genes include MKI67, PCNA, CCND1, CDK4, CDK6, MYC, TP53, RB1, EGFR, KRAS, PIK3CA, MTOR, and metabolic genes like GLUL.
How is cell population proliferation measured?
Common methods include EdU/BrdU incorporation, MTT assays, CFSE dilution, Ki-67 staining, and real-time cell analysis.
What diseases are associated with dysregulated proliferation?
Cancer, fibrosis, autoimmune disorders, and genetic disorders like Wilson's disease [1, 3, 4, 5].
What is the role of MafB in proliferation?
MafB restricts local monocyte proliferation before lung interstitial macrophage differentiation.
Can CRISPR be used to study proliferation?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to test gene function in proliferation.
What is the GO ID for cell population proliferation?
The GO ID is GO:0008283.
How does metabolism affect proliferation?
Metabolic reprogramming, such as activation of OXPHOS via glutamine metabolism, supports proliferation in bladder cancer.
Do proliferation rates vary between individuals?
Yes, studies using HapMap cell lines show population differences in proliferation rates.
What is the link between proliferation and fibrosis?
Multiple stromal populations contribute to pulmonary fibrosis via proliferation without epithelial-to-mesenchymal transition.
Conclusion
Cell population proliferation (GO:0008283) is a central biological process that drives tissue development, homeostasis, and disease. Its regulation involves a complex interplay of cell cycle, metabolic, and microenvironmental factors, as illustrated by studies on monocytes, cancer metabolism, and fibrosis [2, 4, 5]. Understanding the genes and mechanisms controlling proliferation is essential for developing targeted therapies. CRISPR-based models and advanced screening methods offer powerful tools to dissect these pathways and identify new therapeutic targets.
References
- 1. Qin F et al.. 2016. Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer.. Cancer Lett 380(1):39-46 PMID: 27322736
- 2. Vanneste D et al.. 2023. MafB-restricted local monocyte proliferation precedes lung interstitial macrophage differentiation.. Nat Immunol 24(5):827-840 PMID: 36928411
- 3. Huang C et al.. 2022. Genetic studies discover novel coding and non-coding mutations in patients with Wilson's disease in China.. J Clin Lab Anal 36(6):e24459 PMID: 35470480
- 4. Rock JR et al.. 2011. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition.. Proc Natl Acad Sci U S A 108(52):E1475-83 PMID: 22123957
- 5. Kami Reddy KR et al.. 2024. Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer.. JCI Insight 9(17) PMID: 39253977
- 6. Bertrand JU et al.. 2020. Melanoma Risk and Melanocyte Biology.. Acta Derm Venereol 100(11):adv00139 PMID: 32346747
- 7. Stark AL et al.. 2010. Population differences in the rate of proliferation of international HapMap cell lines.. Am J Hum Genet 87(6):829-33 PMID: 21109222
- 8. Willoughby PB et al.. 1988. Analysis of a murine B cell lymphoma, CH44, with an associated non-neoplastic T cell population. I. Proliferation of normal T lymphocytes is induced by a secreted product of the malignant B cells.. Am J Pathol 133(3):507-15 PMID: 2974241
